Fig. 1From: Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD studySurvival analysis of the time to ≥15-letter improvement in best-corrected visual acuity (BCVA) from baseline. *P < 0.001 vs sham (log-rank test comparing cumulative response rate curves over time). DEX 0.7 = dexamethasone intravitreal implant 0.7 mgBack to article page